LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced breast cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called SPH4336 combined with hormone therapy for people with a certain type of advanced breast cancer (HR-positive, HER2-negative) that has gotten worse after standard treatment. About 254 participants will receive the combination to see if it shrinks …
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated May 17, 2026 04:24 UTC
-
New hope for advanced breast cancer patients: experimental combo enters final testing phase
Disease control Recruiting nowThis study tests whether a new drug called SIM0270, combined with everolimus, can slow down or stop the growth of a certain type of advanced breast cancer (ER+/HER2-) that has already been treated with CDK4/6 inhibitors. About 460 participants will receive either the experimental…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for Hard-to-Treat breast cancer: phase 3 trial launches
Disease control Recruiting nowThis study tests a new drug, HRS-8080, combined with dalpiciclib against a standard treatment (fulvestrant plus dalpiciclib) in 912 women with advanced breast cancer that no longer responds to hormone therapy. The goal is to see which combination better delays cancer growth. Part…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:55 UTC